𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evidence for a role of FGF-2 and FGF receptors in the proliferation of non-small cell lung cancer cells

✍ Scribed by Walter Berger; Ulrike Setinek; Thomas Mohr; Ingela Kindas-Mügge; Monika Vetterlein; Gerhard Dekan; Franz Eckersberger; Carlos Caldas; Michael Micksche

Publisher
John Wiley and Sons
Year
1999
Tongue
French
Weight
375 KB
Volume
83
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Basic fibroblast growth factor (FGF-2) has been implicated in the progression of human tumours via both autocrine and paracrine (angiogenic) activities. We investigated the expression of FGF-2 and FGF receptors (FGFR-1 to -4) in NSCLC cell lines (N ‫؍‬ 16), NSCLC surgical specimens (N ‫؍‬ 21) and 2 control cell lines. Our data show that almost all NSCLC cells produce elevated levels of FGF-2 and FGFR in vitro and in vivo. FGF-2 expression did correlate with a short doubling time as well as with potent anchorage-independent growth of NSCLC cell lines. In contrast with control cells, NSCLC cells did not secrete considerable amounts of FGF-2 into the extracellular space. Expression levels of FGFR-1 and -2 in NSCLC cell lines correlated with FGF-2 production. FGFR were located at the plasma membranes in some low FGF-2-producing NSCLC and control cell lines. These cells were sensitive to the proliferative effect of recombinant FGF-2 (rFGF-2). In NSCLC cell lines with an enhanced FGF-2 production, representing the majority studied, FGFR localisation was predominantly intracellular. These cells were insensitive to both the proliferative effect of rFGF-2 and growth inhibition by FGF-2neutralising antibodies. In contrast, several agents antagonised FGF-2 intracellularly impaired growth of almost all NSCLC cell lines. Our data suggest a role of FGF-2 and FGFR in the growth stimulation of NSCLC cells possibly via an intracrine mechanism.

📜 SIMILAR VOLUMES

Potential role of bcl-2 as a suppressor
Potential role of bcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer
✍ Michael I. Koukourakis; Alexandra Giatromanolaki; Kenneth J. O'Byrne; Ruth M. Wh 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 231 KB 👁 1 views

It has been reported that genes regulating apoptosis may play a role in tumoral angiogenesis. This study examined the relationship between tumour vascularization, a measure of tumour angiogenesis, and bcl-2 and p53 expression in operable non-small-cell lung cancer (NSCLC). The relationship between b

CD80 expression in an HLA-A2-positive hu
CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer
✍ Dale L. Bixby; John R. Yannelli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB 👁 1 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix

Frequent loss of heterozygosity in early
Frequent loss of heterozygosity in early non-small cell lung cancers at chromosome 9p21 proximal to the CDKN2a gene
✍ Leeanne J. Mead; Matthew T. Gillespie; Jaclyn Y. Hung; Usha S. Rane; Kathleen C. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 105 KB 👁 1 views

Deletions involving the chromosome 9p21 region have been reported as frequent events in non-small cell lung cancer (NSCLC). To investigate potential tumor-suppressor gene (TSG) loci within the 9p21 region, which also harbors the candidate TSG locus CDKN2a, we studied 32 cases of primary NSCLC for lo

Correlation between methylation status o
Correlation between methylation status of the p16/CDKN2 gene and the expression of p16 and Rb proteins in primary non-small cell lung cancers
✍ Kenji Kashiwabara; Tetsunari Oyama; Takaaki Sano; Toshio Fukuda; Takashi Nakajim 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 423 KB

In order to clarify the frequency of p16 gene inactivation and its relationship with Rb expression, immunohistochemical analysis of p16 and Rb proteins was carried out on 82 paraffin-embedded sections of primary non-small cell lung cancers (NSCLCs). From immunohistochemical results, abnormal p16 exp

Combination chemotherapy with and withou
Combination chemotherapy with and without the methanol-extracted residue of bacillus calmette-guerin (MER) in extensive non-small-cell lung cancer: A prospective randomized study for the piedmont oncology association
✍ Frederick Richards II; Virginia Howard; Anita Shore; Hyman B. Muss; Douglas R. W 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

One-hundred-three patients with extensive non-small-cell lung cancer were entered into a prospective, randomized trial to determine the value of MER as an adjuvant to chemotherapy. Patients were stratified according to histology and performance status. All patients received CCNU, methotrexate, and A